We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App




New QC Reagents Compatible with Multiple Immunoassay Platforms

By LabMedica International staff writers
Posted on 22 Sep 2019
Print article
Image: The new Acusera quality control reagents are designed for cost-effectiveness, as well as accurate and reproducible results (Photo courtesy of Randox).
Image: The new Acusera quality control reagents are designed for cost-effectiveness, as well as accurate and reproducible results (Photo courtesy of Randox).
A new set of infectious disease (serology) quality control reagents is designed to deliver a cost-effective, high-quality solution for the analysis of infectious diseases, while producing repeatable trustworthy results on various immunoassay platforms.

The Randox (Crumlin, United Kingdom) Quality Control Acusera Infectious Disease Serology Controls cover a wide range of infectious diseases, including HIV, hepatitis, EBV, CMV, Varicella zoster virus, ToRCH, Lyme disease and others. These controls are compatible for use on some of the most popular immunoassay platforms including Roche, Abbott, Siemens and Beckman among others.

The Acusera control reagents are manufactured from human plasma, and each control is designed to react to the test system in the same manner as the patient sample. The new controls meet ISO 15189:2012 requirements and reduce inconvenient shifts in QC results when reagent batches are changed.

The reagents, which have been optimized for use by microbiology and virology laboratories, blood banks, public health laboratories, and clinical laboratories performing serology testing, have working stability of 60 days.

Lynsey Adams, Quality Control Manager at Randox, said, “These controls are the first of their kind on the market to be used on a wide range of immunoassay analyzers. Unlike the current practice of analyzer-specific tests, these controls can be used across a wide range of laboratory technologies and, with a working stability of 60 days at two to eight degrees Celsius, waste and costs are kept to a minimum.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.